Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
| CD137L, a driver of harmful inflammation in the nervous system. | Neural Regen Res | 2023 | 37282461 | PubTator, text mining | PubMed |
| Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer. | Sci Rep | 2023 | 37277450 | PubTator, text mining | PubMed |
| Therapeutic strategies to enhance immune response induced by multiple myeloma cells. | Front Immunol | 2023 | 37275861 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| Soluble NKG2D ligands impair CD8+ T cell antitumor function dependent of NKG2D downregulation in neuroblastoma. | Oncol Lett | 2023 | 37274476 | PubTator, text mining | PubMed |
| Deciphering immune microenvironment and cell evasion mechanisms in human gliomas. | Front Oncol | 2023 | 37274252 | PubTator, text mining | PubMed |
| Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway. | Aging (Albany NY) | 2023 | 37263638 | PubTator, text mining | PubMed |
| An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity. | Cell Mol Biol Lett | 2023 | 37259060 | PubTator, text mining | PubMed |
| Risk prediction for dermatomyositis-associated hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37259059 | PubTator, text mining | PubMed |
| Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer. | Sci Rep | 2023 | 37258567 | PubTator, text mining | PubMed |
| Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. | Sci Transl Med | 2023 | 37256936 | PubTator, text mining | PubMed |
| Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq. | Front Immunol | 2023 | 37256127 | PubTator, text mining | PubMed |
| Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins. | Front Immunol | 2023 | 37256126 | PubTator, text mining | PubMed |
| Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. | Biomedicines | 2023 | 37238995 | PubTator, text mining | PubMed |
| A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity. | J Transl Med | 2023 | 37226226 | PubTator, text mining | PubMed |
| Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation. | Nat Cancer | 2023 | 37217652 | PubTator, text mining | PubMed |
| Editorial: Advances in brain tumors diagnosis and treatment. | Front Med (Lausanne) | 2023 | 37215713 | PubTator, text mining | PubMed |
| In Vitro Effects of Low-energy Ultrasound Treatment on Healthy CD3/CD8+ Lymphocytes, Red blood cells, Acute Myeloid leukemia cells, and Jurkat cell line. | J Cancer | 2023 | 37215443 | PubTator, text mining | PubMed |
| Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells. | Front Cell Dev Biol | 2023 | 37215092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=23